NDC 0591-0301 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-0301
- Package NDCs from labels
- 0591-0301-01, 0591-0301-10
- Manufacturer
- Watson Labs
- Effective date
- 2007-05-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Watson Labs | Watson Labs | 2007-05-28 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0591-0301-01 | Furosemide | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 0591-0301-10 | Furosemide | 1000 in 1 BOTTLE | TABLET | 1000 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Furosemide | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 | |
| Furosemide | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 | |
| Corn starch | INACTIVE INGREDIENT | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 | ||
| Lactose monohydrate | INACTIVE INGREDIENT | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 | ||
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 | |
| Microcrystalline cellulose | INACTIVE INGREDIENT | FUROSEMIDE (FUROSEMIDE) TABLET [WATSON LABS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | Preferred Pharmaceuticals Inc. | adda78ee-0cf5-4613-a748-5d6571afe354 | 2026-01-19 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | AvKARE | d4c532be-1f3f-60d3-e053-2995a90a98be | 2026-01-14 | Warnings, Adverse reactions | 313988 197732 310429 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 8f56d6f6-a5ea-4171-9e24-d2fdb11a65f8 | 2026-01-13 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | Northwind Health Company, LLC | 13ba97a7-598a-76a4-e063-6294a90a45c5 | 2026-01-02 | Warnings, Adverse reactions | 310429 |
| FUROSEMIDE | FUROSEMIDE | Northwind Health Company, LLC | 1d99e151-75ba-6a75-e063-6294a90a4360 | 2026-01-01 | Warnings, Adverse reactions | 313988 310429 |
| Furosemide | FUROSEMIDE | Northwind Health Company, LLC | f2b920b2-f8b3-1e6e-e053-2a95a90ae153 | 2026-01-01 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | Northwind Health Company, LLC | f3173c0d-2b62-7c7b-e053-2995a90ada05 | 2026-01-01 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | Redpharm Drug | 3745be12-ea1d-f450-e063-6294a90a148c | 2025-12-24 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 54a33042-a163-4f93-96cc-fbd93030e014 | 2025-12-05 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 6864b3f6-c5ad-4588-ad04-5260258c6d8c | 2025-12-05 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | QPharma Inc | 341e29d9-a6f1-4c77-ae44-9b2c423ea6b4 | 2025-12-03 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | Hikma Pharmaceuticals USA Inc. | 9e493331-dddd-496e-abf8-61747fb67aba | 2025-11-03 | Warnings, Adverse reactions | 313988 197732 310429 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 7842eeab-decf-47e7-9134-0add90549a3d | 2025-10-16 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | e20257f6-7cfe-43fa-a672-cc1cb312b83a | 2025-10-16 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals, Inc. | 20eecc36-dfb7-0060-e063-6394a90a9d0b | 2025-10-16 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | ac64c926-88e9-453a-884c-72ec6a1c746a | 2025-10-15 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 3f3248cd-d62f-49ca-8788-f059e8facd91 | 2025-10-15 | Warnings, Adverse reactions | 310429 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | c81d313c-65a3-4fb5-b6cd-b1c1ec7dca03 | 2025-10-15 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 5d7eb469-2371-4abb-8f49-be1596f10f27 | 2025-10-15 | Warnings, Adverse reactions | 313988 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 85375079-a9f1-42d4-8e15-c1d31395b29d | 2025-10-15 | Warnings, Adverse reactions | 310429 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.